While semaglutide has been widely studied, there are still questions about rare or unexpected side effects
The research from the FDA Adverse Event Reporting System revealed elevated reporting odds ratios for alopecia with semaglutide (2.46) and tirzepatide (1.73), though notably not with older GLP-1 medications like liraglutide or dulaglutide
By incorporating probiotics and prebiotics into your diet, prioritizing fiber, staying hydrated, managing stress, and ensuring proper sleep and exercise, you can support your gut microbiome in returning to balance
GLP-1 drugs are not a permanent fix, they manage some symptoms while you take them
Novo Nordisk and Eli Lilly have repeatedly argued that regulators have not acted aggressively enough against copycat products
Recent head-to-head clinical trials have directly compared tirzepatide (e.g., Zepbound) to semaglutide (e.g., Wegovy) for weight loss in individuals with obesity but without diabetes